ethylcholine aziridinium has been researched along with Disease Models, Animal in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (34.62) | 18.7374 |
| 1990's | 5 (19.23) | 18.2507 |
| 2000's | 9 (34.62) | 29.6817 |
| 2010's | 2 (7.69) | 24.3611 |
| 2020's | 1 (3.85) | 2.80 |
| Authors | Studies |
|---|---|
| Ban, YH; Choi, EK; Joo, SS; Kim, TM; Kim, YB; Park, D | 1 |
| Bachurin, SO; Lermontova, NN; Nikolaeva, NS; Serkova, TP; Shevtsova, EF; Van'kin, GI; Vasilieva, NA | 1 |
| Ban, YH; Cha, Y; Choi, EK; Guo, H; Jang, GY; Jang, SK; Jeong, HS; Joo, SS; Kim, YB; Lee, JY; Lee, SH; Park, D; Yeon, S | 1 |
| Blei, K; Dirnagl, U; Harms, C; Harms, U; Hörtnagl, H; Kapinya, KJ; Katchanov, J | 1 |
| Dudas, B; Hanin, I; Rose, M; Wülfert, E | 1 |
| Cornelli, U; Dudas, B; Hanin, I; Rose, M | 1 |
| Daniel, C; Geisslinger, G; Radeke, HH; Sartory, N; Stein, JM; Zahn, N | 1 |
| Berdiev, RK; Chepurnov, SA; Chepurnova, NE; van Luijtelaar, G; Veening, JG | 1 |
| Chakravarti, S; Wu, F | 1 |
| Bessho, T; Eguchi, J; Komatsu, T; Saito, K; Takashina, K | 1 |
| Potter, PE; Thorne, B | 1 |
| Hanin, I | 2 |
| El Tamer, A; Hanin, I; Wülfert, E | 1 |
| Bartolomeo, AC; Boast, CA; Morris, H | 1 |
| Kubo, T; Nakamura, S; Nishiike, S; Takeda, N; Uno, A; Yamatodani, A | 1 |
| Bachurin, SO; Lermontova, NN; Lukoyanov, NV; Lukoyanova, EA; Serkova, TP | 1 |
| Arendash, GW; Meyer, EM; Mouton, PR | 1 |
| Brandeis, R; Dachir, S; Fisher, A; Heldman, E; Karton, I; Levy, A; Pittel, Z; Sapir, M | 1 |
| Fisher, A; Hanin, I | 1 |
| Iga, Y; Kawanishi, G; Mizobe, F; Nakahara, N | 1 |
| Ikeda, H; Okano, T; Yamashita, M; Yoshimura, K | 1 |
| Cuello, AC; Stephens, PH; Tagari, P | 1 |
| Lammers, AJ; Steinbusch, HW; Tonnaer, JA; Wieringa, JH | 1 |
| Jarrard, LE; Kant, GJ; Levy, A; Meyerhoff, JL | 1 |
| Abraham, DJ; Hanin, I; Mistry, JS | 1 |
3 review(s) available for ethylcholine aziridinium and Disease Models, Animal
| Article | Year |
|---|---|
The AF64A model of cholinergic hypofunction: an update.
Topics: Animals; Aziridines; Brain; Choline; Choline Deficiency; Cholinergic Antagonists; Disease Models, Animal; Neurons; Neurotoxins; Synaptic Transmission | 1996 |
Cholinergic toxins and Alzheimer's disease.
Topics: Acetylcholine; Alzheimer Disease; Animals; Aziridines; Choline; Disease Models, Animal; Humans; Neurotoxins; Parasympathomimetics | 1992 |
Potential animal models for senile dementia of Alzheimer's type, with emphasis on AF64A-induced cholinotoxicity.
Topics: Aged; Aging; Aluminum; Alzheimer Disease; Animals; Aziridines; Choline; Disease Models, Animal; Haplorhini; Hemicholinium 3; Humans; Neuromuscular Blocking Agents; Neurotoxins; Parasympathetic Nervous System; Scopolamine | 1986 |
23 other study(ies) available for ethylcholine aziridinium and Disease Models, Animal
| Article | Year |
|---|---|
Effectiveness of Combinational Treatments for Alzheimer's Disease with Human Neural Stem Cells and Microglial Cells Over-Expressing Functional Genes.
Topics: Acetylcholine; Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Disease Models, Animal; Humans; Memory Disorders; Mice; Microglia; Neprilysin; Neural Stem Cells | 2023 |
Wave-Like Dose-Dependence of the Stimulating Effects of Dimebon on Cognition in a Wide Dose Range.
Topics: Alzheimer Disease; Animals; Aziridines; Biological Clocks; Central Nervous System Stimulants; Choline; Cognition; Disease Models, Animal; Dose-Response Relationship, Drug; Indoles; Maze Learning; Mice; Mice, Inbred C57BL; Pattern Recognition, Physiological; Rats; Rats, Wistar | 2019 |
A silk peptide fraction restores cognitive function in AF64A-induced Alzheimer disease model rats by increasing expression of choline acetyltransferase gene.
Topics: Alzheimer Disease; Animals; Avoidance Learning; Aziridines; Cell Line, Tumor; Choline; Choline O-Acetyltransferase; Cognition; Disease Models, Animal; Gene Expression Regulation, Enzymologic; Insect Proteins; Male; Maze Learning; Peptide Fragments; Rats; Rats, Sprague-Dawley; Silk | 2017 |
Role of NAD(P)H:quinone oxidoreductase in the progression of neuronal cell death in vitro and following cerebral ischaemia in vivo.
Topics: Animals; Apoptosis; Aziridines; Brain Ischemia; Cells, Cultured; Choline; Dicumarol; Disease Models, Animal; Disease Progression; Drug Synergism; Enzyme Activation; Enzyme Inhibitors; Hydroquinones; Male; Mice; Mice, Inbred C57BL; NAD(P)H Dehydrogenase (Quinone); NADPH Dehydrogenase; Neurons; Rats; Rats, Wistar | 2003 |
Protection against inflammatory neurodegeneration and glial cell death by 7beta-hydroxy epiandrosterone, a novel neurosteroid.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Aziridines; Cell Death; Choline; Choline O-Acetyltransferase; Cholinergic Fibers; Dehydroepiandrosterone; Disease Models, Animal; Encephalitis; Glial Fibrillary Acidic Protein; Gliosis; Hippocampus; Immunohistochemistry; Male; Nerve Degeneration; Neuroglia; Neuroprotective Agents; Peptide Fragments; Rats; Rats, Inbred F344; Septal Nuclei; tau Proteins | 2004 |
Glycosaminoglycan C3 protects against AF64A-induced cholinotoxicity in a dose-dependent and time-dependent manner.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Aziridines; Cell Death; Choline; Choline O-Acetyltransferase; Cholinergic Fibers; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Glycosaminoglycans; Heparinoids; Hippocampus; Male; Neuroprotective Agents; Neurotoxins; Rats; Rats, Inbred F344 | 2004 |
FTY720 ameliorates Th1-mediated colitis in mice by directly affecting the functional activity of CD4+CD25+ regulatory T cells.
Topics: Animals; Antigens, CD; Antigens, Differentiation; Aziridines; Cell Differentiation; Choline; Colitis; CTLA-4 Antigen; Cytokines; Disease Models, Animal; Down-Regulation; Fingolimod Hydrochloride; Forkhead Transcription Factors; Immunosuppressive Agents; Inflammation; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Mice; Mice, Inbred BALB C; Neuromuscular Blocking Agents; Propylene Glycols; Sphingosine; T-Lymphocytes, Regulatory; Th1 Cells | 2007 |
The role of the nucleus basalis of Meynert and reticular thalamic nucleus in pathogenesis of genetically determined absence epilepsy in rats: a lesion study.
Topics: Animals; Antibodies, Monoclonal; Aziridines; Basal Nucleus of Meynert; Behavior, Animal; Choline; Choline O-Acetyltransferase; Disease Models, Animal; Electroencephalography; Epilepsy, Absence; Functional Laterality; Male; Rats; Rats, Inbred Strains; Ribosome Inactivating Proteins, Type 1; Saporins; Thalamic Nuclei | 2007 |
Differential expression of inflammatory and fibrogenic genes and their regulation by NF-kappaB inhibition in a mouse model of chronic colitis.
Topics: Animals; Aziridines; CD4-Positive T-Lymphocytes; Choline; Chronic Disease; Colitis, Ulcerative; Crohn Disease; Disease Models, Animal; Extracellular Matrix; Female; Fibrosis; Gene Expression Profiling; Gene Expression Regulation; Inflammation; Macrophages; Mice; Neuromuscular Blocking Agents; Neutrophil Infiltration; Neutrophils; Oligodeoxyribonucleotides, Antisense; Oligonucleotide Array Sequence Analysis; Time Factors; Transcription Factor RelA | 2007 |
MKC-231, a choline-uptake enhancer: (1) long-lasting cognitive improvement after repeated administration in AF64A-treated rats.
Topics: Animals; Aziridines; Behavior, Animal; Brain; Carbon Isotopes; Choline; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Hippocampus; Learning Disabilities; Male; Maze Learning; Quinolines; Rats; Rats, Wistar; Synaptosomes; Time Factors | 2008 |
Lesion with the neurotoxin AF64A alters hippocampal cholinergic receptor function.
Topics: Acetylcholine; Alzheimer Disease; Animals; Aziridines; Choline; Disease Models, Animal; Electric Stimulation; Hippocampus; In Vitro Techniques; Injections, Intraventricular; Male; Neurotoxins; Nicotine; Oxotremorine; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Cholinergic; Stimulation, Chemical | 1995 |
Age-dependent effect of AF64A on cholinergic activity in the septo-hippocampal pathway of the rat brain: decreased responsiveness in aged rats.
Topics: Acetylcholinesterase; Aging; Alzheimer Disease; Animals; Aziridines; Choline; Choline O-Acetyltransferase; Cholinergic Antagonists; Cholinergic Fibers; Disease Models, Animal; Enzyme Induction; Hippocampus; Injections, Intraventricular; Male; Nerve Tissue Proteins; Rats; Rats, Sprague-Dawley; Septum Pellucidum | 1996 |
Arecoline via miniosmotic pump improves AF64A-impaired radial maze performance in rats: a possible model of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Arecoline; Aziridines; Brain; Brain Mapping; Cerebral Cortex; Choline; Disease Models, Animal; Dose-Response Relationship, Drug; Hippocampus; Infusion Pumps, Implantable; Male; Maze Learning; Mental Recall; Muscarinic Agonists; Neurotoxins; Rats; Rats, Sprague-Dawley; Retention, Psychology | 1997 |
Cholinergic influence on vestibular stimulation-induced locus coeruleus inhibition in rats.
Topics: Animals; Aziridines; Caloric Tests; Choline; Cholinergic Fibers; Disease Models, Animal; Electrodes, Implanted; Locus Coeruleus; Male; Motion Sickness; Muscarinic Antagonists; Neuromuscular Blocking Agents; Rats; Rats, Sprague-Dawley; Scopolamine; Time Factors; Vestibule, Labyrinth | 2000 |
Dimebon improves learning in animals with experimental Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Avoidance Learning; Aziridines; Choline; Cholinesterase Inhibitors; Disease Models, Animal; Histamine H1 Antagonists; Indoles; Injections, Intraventricular; Male; Neuromuscular Blocking Agents; Rats; Rats, Wistar; Tacrine | 2000 |
Intracortical AF64A: memory impairments and recovery from cholinergic hypofunction.
Topics: Acetylcholine; Alzheimer Disease; Animals; Avoidance Learning; Aziridines; Biological Transport; Cerebral Cortex; Choline; Disease Models, Animal; Memory; Rats; Rats, Inbred Strains; Time Factors | 1989 |
(+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3') quinuclidine (AF102B): a new M1 agonist attenuates cognitive dysfunctions in AF64A-treated rats.
Topics: Alzheimer Disease; Animals; Aziridines; Behavior, Animal; Choline; Cognition Disorders; Disease Models, Animal; Drug Design; Male; Molecular Structure; Parasympathomimetics; Quinuclidines; Rats; Rats, Inbred Strains; Receptors, Muscarinic; Thiophenes | 1989 |
Effects of intracerebroventricular injection of AF64A on learning behaviors in rats.
Topics: Alzheimer Disease; Amnesia; Animals; Avoidance Learning; Aziridines; Azirines; Choline; Choline O-Acetyltransferase; Disease Models, Animal; Hippocampus; Injections, Intraventricular; Learning; Male; Physostigmine; Rats; Rats, Inbred Strains | 1988 |
Neurochemical effects following AF64A injection into the basal nuclei of rats.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Aziridines; Azirines; Basal Ganglia; Choline; Choline O-Acetyltransferase; Disease Models, Animal; Dose-Response Relationship, Drug; Injections, Intraventricular; Male; Neural Pathways; Neuromuscular Blocking Agents; Rats; Rats, Inbred Strains; Septal Nuclei; Substantia Innominata | 1987 |
Ethylcholine mustard aziridinium ion lesions of the rat cortex result in retrograde degeneration of basal forebrain cholinergic neurons: implications for animal models of neurodegenerative disease.
Topics: Alzheimer Disease; Animals; Aziridines; Azirines; Basal Ganglia; Cerebral Cortex; Choline; Choline O-Acetyltransferase; Cholinergic Fibers; Disease Models, Animal; Male; Nerve Degeneration; Rats; Rats, Inbred Strains; Receptors, Cholinergic; Retrograde Degeneration; Substantia Innominata | 1987 |
Immunohistochemical evidence for degeneration of cholinergic neurons in the forebrain of the rat following injection of AF64A-picrylsulfonate into the dorsal hippocampus.
Topics: Alzheimer Disease; Animals; Aziridines; Azirines; Choline; Choline O-Acetyltransferase; Cholinergic Fibers; Diencephalon; Disease Models, Animal; Hippocampus; Rats; Rats, Inbred Strains; Serotonin; Telencephalon; Trinitrobenzenesulfonic Acid | 1986 |
Intracerebral injections of AF64A: an animal model of Alzheimer's disease?
Topics: Alzheimer Disease; Animals; Aziridines; Azirines; Brain; Choline; Cholinergic Fibers; Disease Models, Animal; Humans; Injections, Intraventricular; Mental Recall; Neuromuscular Blocking Agents; Rats | 1985 |
Neurochemistry of aging. 1. Toxins for an animal model of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Aziridines; Azirines; Binding, Competitive; Biological Transport; Brain Chemistry; Choline; Disease Models, Animal; In Vitro Techniques; Mice; Models, Molecular; Parasympathetic Nervous System; Quinuclidinyl Benzilate; Receptors, Muscarinic; Structure-Activity Relationship; Synaptosomes; Toxins, Biological | 1986 |